Similarly, exosomes produced by human solid cancers, including prostate cancer [48] and ovarian cancer [49], can selectively downregulate NKG2D levels on NK cells by expressing NKG2D ligands, ultimately leading to impaired NK cell-mediated cytotoxic function and promotion of tumor immune evasion. The gene discussed is KLRK1; the disease is prostate carcinoma.